World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
147
Citations
96752
World Ranking
1263
National Ranking
732

Overview

Richard Stone is affiliated with Harvard University in the United States and has a research focus primarily in the field of Medicine. Their work spans several subfields including Emergency Medicine, Cardiology and Cardiovascular Medicine, Clinical Psychology, Public Health, Environmental and Occupational Health, and Reproductive Medicine.

Their research topics cover areas such as Emergency and Acute Care Studies, Science, Research, and Medicine, Acute Myocardial Infarction Research, Cardiac Arrest and Resuscitation, Psychiatric care and mental health services, Healthcare Decision-Making and Restraints, and Japanese History and Culture.

Stone has multiple recent publications in academic journals, with selected papers including:

  • Recent amendments to Queensland legislation make mental health presentations to hospital emergency departments more difficult to scrutinise (2021) published in Emergency Medicine Australasia
  • Value of single troponin values in the emergency department for excluding acute myocardial infarction in Aboriginal and Torres Strait Islander people (2022) published in The Medical Journal of Australia
  • Emergency Department Assessment of Suspected Acute Coronary Syndrome Using the IMPACT Pathway in Aboriginal and Torres Strait Islander People (2022) published in Heart Lung and Circulation
  • Clinical characteristics of Aboriginal and Torres Strait Islander emergency department patients with suspected acute coronary syndrome (2022) published in Emergency Medicine Australasia
  • Emergency examination authorities in Queensland, Australia (2023) published in Emergency Medicine Australasia

Frequent coauthors working collaboratively with Stone include Laura Stephensen, Katrina Starmer, G. Starmer, William Parsonage, and Tileah Drahm-Butler.

Their publications appear frequently in several venues, such as:

  • Science
  • Emergency Medicine Australasia
  • Heart Lung and Circulation
  • Proceedings of the Human Factors and Ergonomics Society Annual Meeting
  • The Medical Journal of Australia

In addition to articles, Stone has authored book publications, including a title published by Boydell and Brewer eBooks titled Bristol and the Birth of the Atlantic Economy, 1500-1700 (2024).

Best Publications

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

    Hagop M Kantarjian;Charles Sawyers;Andreas Hochhaus;Francois Guilhot

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

    Lewis R. Silverman;Erin P. Demakos;Bercedis L. Peterson;Alice B. Kornblith

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

    Alan List;Gordon Dewald;John Bennett;Aristotle Giagounidis

  • Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

    Bruce D. Cheson;Peter L. Greenberg;John M. Bennett;Bob Lowenberg

  • Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

    Charles L. Sawyers;Andreas Hochhaus;Eric Feldman;John M. Goldman

  • Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

    Moshe Talpaz;Richard T. Silver;Brian J. Druker;John M. Goldman

  • Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

    Eytan M. Stein;Eytan M. Stein;Courtney D. DiNardo;Daniel A. Pollyea;Amir T. Fathi

  • Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML

    C. D. DiNardo;E. M. Stein;S. De Botton;G. J. Roboz

  • International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

    Hervé Dombret;John F. Seymour;Aleksandra Butrym;Agnieszka Wierzbowska

  • United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

    Steven L. Soignet;Stanley R. Frankel;Dan Douer;Martin S. Tallman

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III

    DB Simon;RS Bindra;TA Mansfield;C NelsonWilliams

  • CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

    Jeffrey E. Lancet;Geoffrey L. Uy;Jorge E. Cortes;Laura F. Newell

  • Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

    R. Coleman Lindsley;Brenton G. Mar;Emanuele Mazzola;Peter V. Grauman

  • Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

    Marina Konopleva;Daniel A. Pollyea;Jalaja Potluri;Brenda Chyla

  • Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML): Results of a phase I dose-escalation and expansion study.

    Eytan M. Stein;Courtney Denton Dinardo;Daniel Aaron Pollyea;Amir Tahmasb Fathi

Frequent Co-Authors

Daniel J. DeAngelo
Daniel J. DeAngelo Harvard University
Clara D. Bloomfield
Clara D. Bloomfield The Ohio State University
David P. Steensma
David P. Steensma Harvard University
Richard A. Larson
Richard A. Larson University of Chicago
Bayard L. Powell
Bayard L. Powell Wake Forest University
Jonathan E. Kolitz
Jonathan E. Kolitz Hofstra University
Martin S. Tallman
Martin S. Tallman Northwestern University
Donna Neuberg
Donna Neuberg Harvard University
Krzysztof Mrózek
Krzysztof Mrózek The Ohio State University
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine or healthcare, there are many flexible online pathways to consider. For those already possessing an RN license, enrolling in one of the cheapest bsn programs can be a cost-effective way to advance your nursing credentials and career prospects.

Alternatively, if you have a non-nursing bachelor’s degree, some schools offer streamlined entry level msn programs online that allow you to enter the nursing field quickly and efficiently.

Admissions can be competitive, but there are options such as the easiest bsn program to get into for those concerned about acceptance rates. This can open doors to valuable experience and further specializations.

Not all healthcare paths require direct patient care. For administrative roles, consider accredited programs with financial aid for medical billing and coding to get started in a rapidly growing field.

Each of these online options comes with unique entry requirements, costs, and potential for financial aid—making it possible for students from various backgrounds to build a rewarding healthcare career.

Best Scientists Citing Richard Stone

Trending Scientists

Recently Published Articles